Drug Shortage Report for GLUCOPHAGE
| Report ID | 76402 |
| Drug Identification Number | 02162849 |
| Brand name | GLUCOPHAGE |
| Common or Proper name | Glucophage |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | METFORMIN HYDROCHLORIDE |
| Strength(s) | 850MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | A10BA |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2019-03-28 |
| Actual start date | |
| Estimated end date | 2019-05-03 |
| Actual end date | 2019-04-26 |
| Shortage status | Resolved |
| Updated date | 2019-07-19 |
| Company comments | Delay in production |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2019-07-19 | French | Compare |
| v5 | 2019-07-19 | English | Compare |
| v4 | 2019-03-29 | English | Compare |
| v3 | 2019-02-20 | French | Compare |
| v2 | 2019-02-20 | English | Compare |
| v1 | 2019-02-20 | English | Compare |
Showing 1 to 6 of 6